Saturday, February 12, 2022, 8:00 AM – 3:55 PM PST, Webinar

The 2022 Stanford Review of the 63rd Annual ASH Conference has been renamed in remembrance of the late Dr. Steven Coutre (1959-2021), who is deeply missed as an outstanding leader, educator, and investigator in the field of malignant hematology. The conference will highlight cutting-edge research and data on hematologic disorders presented at the conference, as well as provide participants with updated treatment algorithms and strategies for optimizing the care of their patients. The 2022 Stanford Review will utilize a variety of learning modalities, including case studies, panel discussions, and audience response questions, to facilitate meaningful interactions between expert faculty presenters and symposium participants. This webinar will showcase important breakthroughs in the hematology field and improvements in diagnosis and treatment that can be implemented in daily practice.

Registration fee includes course materials and certificate of participation.  Webinar information with the Zoom link will be provided to registered attendees the week of the event.
https://stanford.cloud-cme.com/hematology2022

Registration Rate:
Physicians: $75
Nurses & Allied Health Professionals: $75
Industry: $75

https://stanford.cloud-cme.com/course/courseoverview?P=3000&EID=40283&IsExhibitor=false
Tuition may be paid by Visa, MasterCard or check. Your email address is used for critical information, including registration confirmation, evaluation, and certificate. Be sure to include an email address that you check frequently. If you prefer to pay by phone or check, please contact the Stanford Center for CME at (650) 497-8554 for assistance.

STAP-eligible employees can use STAP funds towards the registration fees for this activity.  Complete the STAP Reimbursement Request Form and submit to your department administrator.

AMA PRA Category 1 Credits™ (8.00 hours), Non-Physician Participation Credit (8.00 hours)

1. Implement the use of new chemotherapeutics and biologics in subpopulations of acute myeloid leukemia patients based on patient clinical and genetic profiles
2. Review new drug approvals and practical considerations for their safe and optimal use
3. Evaluate optimal sequencing and combinations of novel agents for CLL and lymphomas
4. Asses the role of new therapies in non-malignant hematology indications
5. Discuss available therapeutic options for patients with low- or high-risk myelodysplastic syndromes and utilize the revised international prognostic scoring system (IPSS-R) with new mutation data to classify patients for treatment

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation
American Medical Association (AMA)
Stanford Medicine designates this Live Activity for a maximum of 8.00 AMA PRA Category 1 Credits^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

Cancellation Policy
Cancellations received in writing no less than 20 days before the course will be refunded, less a 20% administrative fee. No refunds will be made on cancellations received after that date. Please send cancellation requests to stanfordcme@stanford.edu.

Stanford University School of Medicine reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred such as non-refundable airline tickets or hotel penalties.

Accessibility Statement
Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Conference Coordinator.

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: https://laneguides.stanford.edu/multicultural-health

For activity related questions, please contact
Name: Melissa Schwartz
Title: Events Project Manager
Email: Melissa.schwartz@stanford.edu

For CME general questions, please contact
    Email: stanfordcme@stanford.edu